Inhibitory effects of EGFR antisense oligodeox ynucleotide in human colorectal cancer cell line.
作者信息
He Yong, Zhou Jun, Wu Jin-Sheng, Dou Ke-Feng
出版信息
World J Gastroenterol. 2000 Oct;6(5):747-749. doi: 10.3748/wjg.v6.i5.747.
Abstract
摘要
相似文献
1
Inhibitory effects of EGFR antisense oligodeox ynucleotide in human colorectal cancer cell line.
World J Gastroenterol. 2000 Oct;6(5):747-749. doi: 10.3748/wjg.v6.i5.747.
2
[Inhibitory effects of siRNA targeting epidermal growth factor receptor on proliferation and invasion of human glioblastoma cells].
Zhonghua Yi Xue Za Zhi. 2004 Sep 17;84(18):1503-8.
3
Inhibitory effect of EGFR antisense oligodeoxynucleotide on human hepatoma cell line.
Hepatobiliary Pancreat Dis Int. 2005 Aug;4(3):433-6.
4
The effect of epidermal growth factor receptor antisense morpholino oligomer on non-small cell lung cancer cell line.
Oncol Rep. 2003 Nov-Dec;10(6):1967-71.
5
Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines.
Int J Cancer. 2001 Jul 15;93(2):172-8. doi: 10.1002/ijc.1335.
6
Enhanced antiangiogenic therapy of squamous cell carcinoma by combined endostatin and epidermal growth factor receptor-antisense therapy.
Clin Cancer Res. 2002 Nov;8(11):3570-8.
7
EGFR Downregulation after Anti-EGFR Therapy Predicts the Antitumor Effect in Colorectal Cancer.
Mol Cancer Res. 2017 Oct;15(10):1445-1454. doi: 10.1158/1541-7786.MCR-16-0383. Epub 2017 Jul 11.
8
Suppression of colorectal cancer growth using an adenovirus vector expressing an antisense K-ras RNA.
Mol Ther. 2001 Apr;3(4):491-9. doi: 10.1006/mthe.2001.0302.
9
Improved therapeutic effectiveness by combining recombinant p14(ARF) with antisense complementary DNA of EGFR in laryngeal squamous cell carcinoma.
Am J Otolaryngol. 2015 Nov-Dec;36(6):763-71. doi: 10.1016/j.amjoto.2015.07.012. Epub 2015 Aug 5.
10
Antisense epidermal growth factor receptor (EGFR) transfection down-regulates EGFR expression and suppresses the malignant phenotype of human nasopharyngeal carcinoma CNE-2 cell line.
Di Yi Jun Yi Da Xue Xue Bao. 2003 Sep;23(9):877-81.
引用本文的文献
1
Splice-Switching Antisense Oligonucleotides Targeting Extra- and Intracellular Domains of Epidermal Growth Factor Receptor in Cancer Cells.
Biomedicines. 2023 Dec 13;11(12):3299. doi: 10.3390/biomedicines11123299.
2
Synergistic anti-tumor effect of recombinant chicken fibroblast growth factor receptor-1-mediated anti-angiogenesis and low-dose gemcitabine in a mouse colon adenocarcinoma model.
World J Gastroenterol. 2007 May 7;13(17):2484-9. doi: 10.3748/wjg.v13.i17.2484.
3
Kinase domain insert containing receptor promoter controlled suicide gene system selectively kills human umbilical vein endothelial cells.
World J Gastroenterol. 2006 Sep 7;12(33):5331-5. doi: 10.3748/wjg.v12.i33.5331.
4
Arterial chemotherapy of 5-fluorouracil and mitomycin C in the treatment of liver metastases of colorectal cancer.
World J Gastroenterol. 2002 Aug;8(4):663-7. doi: 10.3748/wjg.v8.i4.663.
5
Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R.
World J Gastroenterol. 2002 Aug;8(4):644-9. doi: 10.3748/wjg.v8.i4.644.
6
Effects of epidermal growth factor on the growth of human gastric cancer cell and the implanted tumor of nude mice.
World J Gastroenterol. 2002 Jun;8(3):455-8. doi: 10.3748/wjg.v8.i3.455.
7
Specific CEA-producing colorectal carcinoma cell killing with recombinant adenoviral vector containing cytosine deaminase gene.
World J Gastroenterol. 2002 Apr;8(2):270-5. doi: 10.3748/wjg.v8.i2.270.
8
Expression and bioactivity identification of soluble MG7 scFv.
World J Gastroenterol. 2002 Feb;8(1):99-102. doi: 10.3748/wjg.v8.i1.99.
9
Early diagnosis for colorectal cancer in China.
World J Gastroenterol. 2002 Feb;8(1):21-5. doi: 10.3748/wjg.v8.i1.21.
本文引用的文献
1
Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides.
Clin Cancer Res. 1996 Mar;2(3):601-9.
2
Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines.
Clin Cancer Res. 1996 Jan;2(1):119-26.
3
Epidermal growth factor receptor expression in primary cultured human colorectal carcinoma cells.
Br J Cancer. 1998 Jun;77(11):1792-8. doi: 10.1038/bjc.1998.298.
4
Inhibition of the epidermal growth factor receptor tyrosine kinase by PD153035 in human A431 tumors in athymic nude mice.
Invest New Drugs. 1996;13(4):295-302. doi: 10.1007/BF00873135.
5
Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression.
Cancer Res. 1996 Aug 1;56(15):3499-507.
6
Anti-epidermal growth factor receptor monoclonal antibody 225 up-regulates p27KIP1 and induces G1 arrest in prostatic cancer cell line DU145.
Cancer Res. 1996 Aug 15;56(16):3666-9.
7
Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy.
Proc Natl Acad Sci U S A. 1996 May 14;93(10):4851-6. doi: 10.1073/pnas.93.10.4851.
8
Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase.
Nat Med. 1996 Jun;2(6):668-75. doi: 10.1038/nm0696-668.
9
Involvement of p27KIP1 in G1 arrest mediated by an anti-epidermal growth factor receptor monoclonal antibody.
Oncogene. 1996 Apr 4;12(7):1397-403.
10
Inhibitory effect of anti-epidermal growth factor receptor antibody on a human gastric cancer.
Cancer. 1996 Apr 15;77(8 Suppl):1639-45. doi: 10.1002/(SICI)1097-0142(19960415)77:8<1639::AID-CNCR33>3.0.CO;2-Z.
Zotero 插件